Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Busenbender

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Oncology Research and Treatment|August 10, 2025
Management of Metastatic Prostate CancerGunhild von Amsberg, Tobias Busenbender, Anja Coym, et al.
Marine Drugs|October 26, 2022
Cytotoxic N-Methylpretrichodermamide B Reveals Anticancer Activity and Inhibits P-Glycoprotein in Drug-Resistant Prostate Cancer CellsSergey A Dyshlovoy, Tobias Busenbender, Jessica Hauschild, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 4, 2025
Transcriptional profiles of circulating tumor cells reflect heterogeneity and treatment resistance in advanced prostate cancerLina Bergmann, Sarah Greimeier, Sabine Riethdorf, et al.
Marine Drugs|January 20, 2023
New Marine Fungal Deoxy-14,15-Dehydroisoaustamide Resensitizes Prostate Cancer Cells to EnzalutamideSergey A Dyshlovoy, Olesya I Zhuravleva, Jessica Hauschild, et al.
Scientific Reports|August 9, 2020
Marine alkaloid monanchoxymycalin C: a new specific activator of JNK1/2 kinase with anticancer propertiesSergey A Dyshlovoy, Moritz Kaune, Malte Kriegs, et al.
Biomolecules|March 19, 2020
Polyphenolic Compounds from Lespedeza Bicolor Root Bark Inhibit Progression of Human Prostate Cancer Cells via Induction of Apoptosis and Cell Cycle ArrestSergey A Dyshlovoy, Darya Tarbeeva, Sergey Fedoreyev, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer CellsSergey A Dyshlovoy, Dmitry N Pelageev, Lea S Jakob, et al.
Scientific Reports|June 20, 2020
Urupocidin C: a new marine guanidine alkaloid which selectively kills prostate cancer cells via mitochondria targetingSergey A Dyshlovoy, Ekaterina K Kudryashova, Moritz Kaune, et al.
Marine Drugs|December 4, 2020
Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer CellsSergey A Dyshlovoy, Moritz Kaune, Jessica Hauschild, et al.
Scientific Reports|May 23, 2024
Synthesis and new DNA targeting activity of 6- and 7-tert-butylfascaplysinsSergey A Dyshlovoy, Wael Y Mansour, Natalia A Ramm, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Oncology Research and Treatment|August 10, 2025
Management of Metastatic Prostate CancerGunhild von Amsberg, Tobias Busenbender, Anja Coym, et al.
Marine Drugs|October 26, 2022
Cytotoxic N-Methylpretrichodermamide B Reveals Anticancer Activity and Inhibits P-Glycoprotein in Drug-Resistant Prostate Cancer CellsSergey A Dyshlovoy, Tobias Busenbender, Jessica Hauschild, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 4, 2025
Transcriptional profiles of circulating tumor cells reflect heterogeneity and treatment resistance in advanced prostate cancerLina Bergmann, Sarah Greimeier, Sabine Riethdorf, et al.
Marine Drugs|January 20, 2023
New Marine Fungal Deoxy-14,15-Dehydroisoaustamide Resensitizes Prostate Cancer Cells to EnzalutamideSergey A Dyshlovoy, Olesya I Zhuravleva, Jessica Hauschild, et al.
Scientific Reports|August 9, 2020
Marine alkaloid monanchoxymycalin C: a new specific activator of JNK1/2 kinase with anticancer propertiesSergey A Dyshlovoy, Moritz Kaune, Malte Kriegs, et al.
Biomolecules|March 19, 2020
Polyphenolic Compounds from Lespedeza Bicolor Root Bark Inhibit Progression of Human Prostate Cancer Cells via Induction of Apoptosis and Cell Cycle ArrestSergey A Dyshlovoy, Darya Tarbeeva, Sergey Fedoreyev, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer CellsSergey A Dyshlovoy, Dmitry N Pelageev, Lea S Jakob, et al.
Scientific Reports|June 20, 2020
Urupocidin C: a new marine guanidine alkaloid which selectively kills prostate cancer cells via mitochondria targetingSergey A Dyshlovoy, Ekaterina K Kudryashova, Moritz Kaune, et al.
Marine Drugs|December 4, 2020
Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer CellsSergey A Dyshlovoy, Moritz Kaune, Jessica Hauschild, et al.
Scientific Reports|May 23, 2024
Synthesis and new DNA targeting activity of 6- and 7-tert-butylfascaplysinsSergey A Dyshlovoy, Wael Y Mansour, Natalia A Ramm, et al.
Pageof 2